Scroll To Top
News

Treatment Update

Treatment Update

Coverx100_334

The National Institutes of Health's Panel on Clinical Practices for Treatment of HIV Infection has recommended that Viread and Videx EC plus a nonnucleoside reverse transciptase inhibitor not be used as in initial regimen for treatment-naive patients because studies show the regimen has a high failure rate. They panel also recommended that Kaletra be dosed once daily for treatment-naive patients. Once-daily Kaletra dosing is not recommended for treatment-experienced patients.

News
Be sure to follow Plus on your favorite social platform
Pride of Broadway Special

From our Sponsors

Most Popular

Lexi Love
News

Lexi Love comes out as HIV+ after Trump deletes federal resources

Grindr's Daddy Lessons.
Sex & Dating

Grindr is reminding us why jockstraps are so sexy and iconic

Doctor Pricking finger Blood Test for donation alongside man with HIV express test mouth swab
News

BREAKING NEWS: Trump admin moves to end federal HIV prevention programs

act up protest
Politics

Trump's orders prompt CDC to erase HIV resources

Rachel Levine former Assistant Secretary Department of Health and Human Services confirmation hearing 2021
Politics

Rachel Levine fought HIV & STIs at HHS. Now she’s speaking out because that progress is being undone

Celebrating Black History Month with our annual African American issue
Print Issue

Celebrating Black History Month with our annual African American issue

SFAF's Dr. Tyler TerMeer says he'll continue to fight for health care for all
Cover Stories

Tyler TerMeer vows to continue to fight for health care for all

Discover the power of Wellness in your life
Print Issue

Discover the power of Wellness in your life

Latest Stories

HIV Plus Editors

Editor

Read Full Bio